Mainz Biomed B.V. (MYNZ)

Mainz Biomed B.V. (MYNZ) Stock Price & Analysis


MYNZ Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.18 - $12.01
Previous Close$5.03
Average Volume (3M)46.29K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$17.14M
Total Debt (Recent Filing)$1.32M
Price to Earnings (P/E)-2.7
Sep 06, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.86
Shares Outstanding14,830,000
10 Day Avg. Volume38,217
30 Day Avg. Volume46,289
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)5.27
Price to Sales (P/S)115.10
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/EbitdaN/A
Price Target Upside118.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Mainz Biomed B.V.’s price range in the past 12 months?
Mainz Biomed B.V. lowest stock price was $3.18 and its highest was $12.01 in the past 12 months.
    What is Mainz Biomed B.V.’s market cap?
    Currently, no data Available
    When is Mainz Biomed B.V.’s upcoming earnings report date?
    Mainz Biomed B.V.’s upcoming earnings report date is Sep 06, 2023 which is in 90 days.
      How were Mainz Biomed B.V.’s earnings last quarter?
      Mainz Biomed B.V. released its earnings results on May 16, 2023. The company reported -$0.45 earnings per share for the quarter, beating the consensus estimate of -$0.49 by $0.04.
        Is Mainz Biomed B.V. overvalued?
        According to Wall Street analysts Mainz Biomed B.V.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Mainz Biomed B.V. pay dividends?
          Mainz Biomed B.V. does not currently pay dividends.
          What is Mainz Biomed B.V.’s EPS estimate?
          Mainz Biomed B.V.’s EPS estimate is -$0.42.
            How many shares outstanding does Mainz Biomed B.V. have?
            Mainz Biomed B.V. has 14,826,612 shares outstanding.
              What happened to Mainz Biomed B.V.’s price movement after its last earnings report?
              Mainz Biomed B.V. reported an EPS of -$0.45 in its last earnings report, beating expectations of -$0.49. Following the earnings report the stock price went down -2.186%.
                Which hedge fund is a major shareholder of Mainz Biomed B.V.?
                Currently, no hedge funds are holding shares in MYNZ


                Mainz Biomed B.V. Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Mainz Biomed B.V.

                Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. It's main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                BioNTech SE

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis